Methods comprising apoptosis inhibitors for the generation of transgenic pigs |
 |
|
|
||||||||||||||||||||||||||||||||||||||||||
| Title: | In-vitro-derived human neutrophil precursor cells |
| Inventors: | Bender, James G.; Lindenhurst, IL, USA Maples, Phillip B.; Waukegan, IL, USA Smith, Stephen L.; Arlington Heights, IL, USA Unverzagt, Kristen L.; Palatine, IL, USA Van Epps, Dennis E.; Cary, IL, USA |
| Summary: | This invention describes a composition of human neutrophil precursor cells consisting of at least 37% myeloblasts and promyeloblasts, and free of bound monoclonal antibodies. Further disclosed are properties of hematopoietic cell suspensions which contain human neutrophil precursor cells and at least one hematopoietic growth factor. Therapeutic applications are described, such as in the treatment of neutropenia that has been induced by high dose chemotherapy. |
| Abstract: | The present invention provides a composition of human neutrophil precursor cells having at least 37% myeloblasts and promyeloblasts. Also provided are hematopoietic cell suspensions that have human neutrophil precursor cells and at least one hematopoietic growth factor. |
| US Patent Website: | Click Here for Full Text of Patent |
| Title Number: | US5955357 |
| Application Number: | US1994000295501 |
| Date Filed: | 23/08/1994 |
| Date Published: | 21/09/1999 |
| Assignee: | Nexell Therapeutics Inc., Irvine, CA, USA |